On-demand webinar offers actionable insights as you develop your protocols.
Many crucial considerations impact a cell and gene therapy developer’s apheresis center selection strategy and ability to efficiently scale processes.
When collection processes or protocols differ from those in place at a center, there are likely implications for training, forms and standard operating procedures. This can potentially delay a first collection.
During the on-demand webinar, our panelists discuss:
- Common protocol decisions cell and gene therapy developers make along the product collection pathway that can impact ability to scale
- Specific considerations for collecting starting material for allogeneic cell therapies
- Factors for post-collection transport and processing to ensure efficient delivery of starting material to the manufacturer
Senior Manager, Collection Network Management
Be The Match BioTherapies®
Network Liaison, Collection Network Management
Be The Match BioTherapies
Program Manager, Oncology
Janssen (A division of J&J)